These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 33584990)

  • 1. Association of interferon lambda-4 rs12979860 polymorphism with hepatocellular carcinoma in patients with chronic hepatitis C infection.
    de Bitencorte JT; Rech TF; Lunge VR; Dos Santos DC; Álvares-da-Silva MR; Simon D
    World J Hepatol; 2021 Jan; 13(1):109-119. PubMed ID: 33584990
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interleukin-28B TT genotype is frequently found in patients with hepatitis C virus cirrhosis but does not influence hepatocarcinogenesis.
    de la Fuente S; Citores MJ; Duca A; Cisneros E; Baños I; Vilches C; Cuervas-Mons V
    Clin Exp Med; 2017 May; 17(2):217-223. PubMed ID: 27083168
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of
    Hou W; Qiao K; Huo Z; Du Y; Wang C; Syn WK
    Clin Exp Gastroenterol; 2019; 12():433-439. PubMed ID: 31807049
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IL-28B rs12979860 polymorphism affect the course of chronic hepatitis and the development of HCC in Egyptian patients with hepatitis C type 4.
    Attallah AM; Omran D; Marie MS; Abdelrazek M; Salama A; El Essawey R; Mobarak L; Maklad S; Omar A
    Br J Biomed Sci; 2018 Oct; 75(4):157-162. PubMed ID: 29914308
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A polymorphism in interferon L3 is an independent risk factor for development of hepatocellular carcinoma after treatment of hepatitis C virus infection.
    Chang KC; Tseng PL; Wu YY; Hung HC; Huang CM; Lu SN; Wang JH; Lee CM; Chen CH; Tsai MC; Yen YH; Lin MT; Wu CK; Huang CC; Chen HH; Hu TH
    Clin Gastroenterol Hepatol; 2015 May; 13(5):1017-24. PubMed ID: 25460552
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Impact of interferon lambda 3 Polymorphism on Hepato-Cellular Carcinoma Progression in Hepatitis C Virus Patients: Treatment-Naïve and Experienced.
    Abd Elrahman M; Ibrahim MK; Khairy A; Yosry A; Zayed N; Tawefeek S; Barakat AZ; Elbatae H; Bader El Din NG
    Asian Pac J Cancer Prev; 2023 Jan; 24(1):215-221. PubMed ID: 36708570
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IL-28B rs12979860 C/T allele distribution in patients with liver cirrhosis: role in the course of chronic viral hepatitis and the development of HCC.
    Fabris C; Falleti E; Cussigh A; Bitetto D; Fontanini E; Bignulin S; Cmet S; Fornasiere E; Fumolo E; Fangazio S; Cerutti A; Minisini R; Pirisi M; Toniutto P
    J Hepatol; 2011 Apr; 54(4):716-22. PubMed ID: 21146242
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interferon lambda 4 (IFNL4) gene polymorphism is associated with spontaneous clearance of HCV in HIV-1 positive patients.
    Alves CF; Grott CS; Lunge VR; Béria JU; Tietzmann DC; Stein AT; Simon D
    Genet Mol Biol; 2016; 39(3):374-9. PubMed ID: 27560987
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of IL28B polymorphism in the development of hepatitis C virus-induced hepatocellular carcinoma, graft fibrosis, and posttransplant antiviral therapy.
    Eurich D; Boas-Knoop S; Bahra M; Neuhaus R; Somasundaram R; Neuhaus P; Neumann U; Seehofer D
    Transplantation; 2012 Mar; 93(6):644-9. PubMed ID: 22411462
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Impact of IFNL4 rs12979860 Polymorphism on Spontaneous Clearance of Hepatitis C; A Case-Control Study.
    Sharafi H; Alavian SM; Behnava B; Pouryasin A; Keshvari M
    Hepat Mon; 2014 Oct; 14(10):e22649. PubMed ID: 25419220
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Polymorphism rs368234815 of interferon lambda 4 gene and spontaneous clearance of hepatitis C virus in haemodialysis patients: a case-control study.
    Grzegorzewska AE; Mostowska A; Świderska MK; Marcinkowski W; Stolarek I; Figlerowicz M; Jagodziński PP
    BMC Infect Dis; 2021 Jan; 21(1):102. PubMed ID: 33482747
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interferon-λ rs12979860 genotype association with liver fibrosis in chronic hepatitis C (CHC) patients in the Pakistani population.
    Rauff B; Amar A; Chudhary SA; Mahmood S; Tayyab GUN; Hanif R
    Arch Virol; 2021 Apr; 166(4):1047-1056. PubMed ID: 33528661
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of functional variants in IFNL4 and IFNL3 for association with HCV clearance.
    O'Brien TR; Pfeiffer RM; Paquin A; Lang Kuhs KA; Chen S; Bonkovsky HL; Edlin BR; Howell CD; Kirk GD; Kuniholm MH; Morgan TR; Strickler HD; Thomas DL; Prokunina-Olsson L
    J Hepatol; 2015 Nov; 63(5):1103-10. PubMed ID: 26186989
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Polymorphisms of interferon-λ4 and IL28B - effects on treatment response to interferon/ribavirin in patients with chronic hepatitis C.
    Stättermayer AF; Strassl R; Maieron A; Rutter K; Stauber R; Strasser M; Beinhardt S; Datz C; Scherzer TM; Steindl-Munda P; Gschwantler M; Trauner M; Hofer H; Ferenci P
    Aliment Pharmacol Ther; 2014 Jan; 39(1):104-11. PubMed ID: 24205831
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    Roy N; Prasad C; Kumar A; Mondol K; Jain K; Yadav R; Jha JK; Nadda N; Acharya SK; Shalimar ; Nayak B
    Virusdisease; 2019 Sep; 30(3):344-353. PubMed ID: 31803800
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Interferon Lambda 4 RS12979860 C>T polymorphism is not associated with liver fibrosis in patients with hepatitis C].
    Brahm J; Urzúa A; Poniachik J; Cáceres DD; Carreño L; Venegas M
    Rev Med Chil; 2018 Jul; 146(7):823-829. PubMed ID: 30534880
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of interferon lambda polymorphisms with elevated baseline viral loads in chronic hepatitis C virus genotype 6 infection.
    Nguyen LT; Van Nguyen D; Carr MJ; Hall WW; Nguyen LA
    Arch Virol; 2018 Jan; 163(1):115-124. PubMed ID: 29022122
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of interleukin-28B single-nucleotide polymorphisms on progression to liver cirrhosis in human immunodeficiency virus-hepatitis C virus-coinfected patients receiving antiretroviral therapy.
    Barreiro P; Pineda JA; Rallón N; Naggie S; Martín-Carbonero L; Neukam K; Rivero A; Benito JM; Caruz A; Vispo E; Camacho A; Medrano J; McHutchison J; Soriano V
    J Infect Dis; 2011 Jun; 203(11):1629-36. PubMed ID: 21592993
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intracellular Accumulation of IFN-λ4 Induces ER Stress and Results in Anti-Cirrhotic but Pro-HCV Effects.
    Onabajo OO; Wang F; Lee MH; Florez-Vargas O; Obajemu A; Tanikawa C; Vargas JM; Liao SF; Song C; Huang YH; Shen CY; Banday AR; O'Brien TR; Hu Z; Matsuda K; Prokunina-Olsson L
    Front Immunol; 2021; 12():692263. PubMed ID: 34497603
    [No Abstract]   [Full Text] [Related]  

  • 20. Genome-Wide Association Study Identifies TLL1 Variant Associated With Development of Hepatocellular Carcinoma After Eradication of Hepatitis C Virus Infection.
    Matsuura K; Sawai H; Ikeo K; Ogawa S; Iio E; Isogawa M; Shimada N; Komori A; Toyoda H; Kumada T; Namisaki T; Yoshiji H; Sakamoto N; Nakagawa M; Asahina Y; Kurosaki M; Izumi N; Enomoto N; Kusakabe A; Kajiwara E; Itoh Y; Ide T; Tamori A; Matsubara M; Kawada N; Shirabe K; Tomita E; Honda M; Kaneko S; Nishina S; Suetsugu A; Hiasa Y; Watanabe H; Genda T; Sakaida I; Nishiguchi S; Takaguchi K; Tanaka E; Sugihara J; Shimada M; Kondo Y; Kawai Y; Kojima K; Nagasaki M; Tokunaga K; Tanaka Y;
    Gastroenterology; 2017 May; 152(6):1383-1394. PubMed ID: 28163062
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.